390 related articles for article (PubMed ID: 28986362)
1. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
[TBL] [Abstract][Full Text] [Related]
2. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2.
Durham KK; Chathely KM; Trigatti BL
Biochem J; 2018 Apr; 475(7):1253-1265. PubMed ID: 29523748
[TBL] [Abstract][Full Text] [Related]
4. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein-mediated transcellular cholesterol transport in mouse aortic endothelial cells.
Miao L; Okoro EU; Cao Z; Yang H; Motley-Johnson E; Guo Z
Biochem Biophys Res Commun; 2015 Sep; 465(2):256-61. PubMed ID: 26255968
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1.
Fung KYY; Ho TWW; Xu Z; Neculai D; Beauchemin CAA; Lee WL; Fairn GD
J Lipid Res; 2024 Apr; 65(4):100530. PubMed ID: 38479648
[TBL] [Abstract][Full Text] [Related]
8. Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.
Traughber CA; Opoku E; Brubaker G; Major J; Lu H; Lorkowski SW; Neumann C; Hardaway A; Chung YM; Gulshan K; Sharifi N; Brown JM; Smith JD
J Biol Chem; 2020 Jun; 295(24):8252-8261. PubMed ID: 32358065
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
[TBL] [Abstract][Full Text] [Related]
10. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
[TBL] [Abstract][Full Text] [Related]
11. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
12. An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells.
Zhang QH; Zu XY; Cao RX; Liu JH; Mo ZC; Zeng Y; Li YB; Xiong SL; Liu X; Liao DF; Yi GH
Biochem Biophys Res Commun; 2012 Mar; 420(1):17-23. PubMed ID: 22390933
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages.
Kluck GEG; Qian AS; Sakarya EH; Quach H; Deng YD; Trigatti BL
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):45-63. PubMed ID: 36353992
[TBL] [Abstract][Full Text] [Related]
14. [Protective effects of high-density lipoprotein on mice cardiomyocytes induced by oxygen and glucose deprivation through Akt signaling pathway].
E L; Cheng Y; Zhao X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):795-799. PubMed ID: 30220284
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
[TBL] [Abstract][Full Text] [Related]
17. Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.
Gao M; Zhao D; Schouteden S; Sorci-Thomas MG; Van Veldhoven PP; Eggermont K; Liu G; Verfaillie CM; Feng Y
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1900-9. PubMed ID: 24969774
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
19. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
[TBL] [Abstract][Full Text] [Related]
20. HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion.
Mancuso E; Mannino GC; Fuoco A; Leo A; Citraro R; Averta C; Spiga R; Russo E; De Sarro G; Andreozzi F; Sesti G
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2941-2952. PubMed ID: 33086869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
